[go: up one dir, main page]

WO2008013362A1 - Anti stomach ulcer or stomach ulcer drug composition - Google Patents

Anti stomach ulcer or stomach ulcer drug composition Download PDF

Info

Publication number
WO2008013362A1
WO2008013362A1 PCT/KR2007/002693 KR2007002693W WO2008013362A1 WO 2008013362 A1 WO2008013362 A1 WO 2008013362A1 KR 2007002693 W KR2007002693 W KR 2007002693W WO 2008013362 A1 WO2008013362 A1 WO 2008013362A1
Authority
WO
WIPO (PCT)
Prior art keywords
freeze
stomach
stomach ulcer
supernatant
earthworms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2007/002693
Other languages
French (fr)
Inventor
Il Hwan Cho
Chul Kyu Lee
Jang Sik Shin
Byung Soo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008013362A1 publication Critical patent/WO2008013362A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Definitions

  • the present invention relates to a composition for preventing or treating stomach ulcers. More specifically, the present invention relates to a composition efficacious in preventing or treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms, and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying.
  • Dried earthworm powders or earthworm extracts have been used for antihyperlipemic, antidiabetic, blood pressure-controlling and antithrombosis drugs. Such use is based on their medical efficacies recorded in Oriental Medicine Literatures (Shinnongbonchogyeong, etc).
  • Oriental Medicine Literatures Shinnongbonchogyeong, etc.
  • the present inventors have demonstrated that lumbrokinase contained in earthworms is efficacious in treating stomach ulcers via repeated research and tests, taking into consideration the facts that earthworms contain a great amount of lumbrokinase, which is one of the proteases, and that a great deal of protease activated receptors (PARs) which have activities for lumbrokinase are present in a human's stomach.
  • PARs protease activated receptors
  • Lumbrokinase contained in earthworms is reported to be a serine-based protease, be considerably stable against heat or pH and exhibit a specific activity for fibrin, which is one of thrombus' ingredients. Lumbrokinase administered orally must be released through the intestines into blood so that it can exert its efficacy. Research associated with this release is considered to be recently conducted.
  • PARs protease activated receptors
  • the present invention has been made to solve the foregoing problems of the prior art and it is an aspect of the present invention to provide a composition for preventing and treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms, and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying.
  • a composition for preventing and treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms, and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying .
  • composition of the present invention is efficacious in preventing and treating stomach ulcers.
  • FIGs. 1 and 2 are photographs showing the gastrointestines of a control group in Example 4 according to the present invention
  • FIGs. 3 and 4 are photographs showing the gastrointestines of a white rat to which Omeprazole is administered in Example 4 according to the present invention
  • FIGs. 5 and 6 are photographs showing the gastrointestines of a white rat to which Stillene is administered in Example 4 according to the present invention.
  • FIGs . 7 and 8 are photographs showing the gastrointestines of a white rat to which a freeze-dried earthworm powder is administered in Example 4 according to the present invention. [Best Mode]
  • the anti-stomach ulcer composition according to the present invention comprises a freeze-dried earthworm powder or a supernatant extracted from earthworms (hereinafter, referred to simply as "earthworm supernatant”) .
  • the anti-stomach ulcer composition contains lumbrokinase , which is one of the proteases, as an active ingredient.
  • a method for preparing the anti-stomach ulcer composition of the present invention comprises: washing raw earthworms with distilled water; wet-grinding the earthworms; centrifuging the earthworms at 2,000 ⁇ g to 4,000*g for 20 to 40 min to obtain a supernatant; and preparing a supernatant-containing composition for preventing and treating stomach ulcers.
  • the method may further comprise filtering the supernatant through diatomaceous silica to remove water- insoluble materials.
  • the method may further comprise freeze-drying the supernatant to prepare a freeze-dried earthworm powder.
  • the preparation of the anti-stomach ulcer composition is carried out using the freeze-dried earthworm powder.
  • the supernatant was filtered through diatomaceous silica to separate water-insoluble materials therefrom.
  • the resulting residue was freeze-dried to prepare a freeze-dried earthworm powder.
  • the weight of the freeze-dried earthworm powder obtained from the raw earthworms (10 Kg) was 1.2 Kg and a titer of a casein digestion was 870 units /g.
  • Example 2 Effects of Stomach Ulcer Protection on Stomach Ulcer Model Induced by Stress 6 week-old white Wistar male rats were used as subjects.
  • Stomach ulcers were induced by a Water-Immersion Restraint Stress Model in which white rats are immersed in a bath. This model is to induce rats to have acute stomach ulcers by forcing the rats to be immersed in a stress cage containing water they hate for 6 hours.
  • a test drug (Stillene ® 60 mg/kg or freeze-dried earthworm powder 50 mg/kg) was administered to the rats at 30 minutes before water-immersion. The temperature of the bath was maintained at 21 ° C to 23 ° C.
  • the stomach of each specimen was enucleated and the pylorus of the stomach was then ligated. Then, 3 mL of a 2% formalin solution was injected through the cardiac orifice and the specimen was fixed for 10 min. After completion of the fixation, the greater curvature of the stomach was excised and washed with physiological saline. The resulting greater curvature was thoroughly spread, fixed on a fixing plate and taken as a photograph. The area of injured site in the photograph was measured with a bio-imaging analyzer.
  • Table 1 Effects of Freeze-dried Earthworm Powder on Stomach Ulcers Induced by Water-Immersion Restraint Stress
  • Stillene ® (Positive control drug): available from Dong-a pharmaceutical Co. , Ltd.
  • Stomach ulcer area is represented by "average ⁇ standard error”.
  • a stomach ulcer-inducing drug used herein was indomethacin, one of non-steroidal anti- inflammatory drugs.
  • the indomethacin was reported to inhibit activity of cyclooxygenase that participates in prostacyclin synthesis in gastric cells, causing gastric injury.
  • a test drug (Stillene * 60 mg/kg or freeze-dried earthworm powder 50 mg/kg) was administered to the Wistar rats, which had been fasted during the overnight prior to testing. After 30 minutes, 20 mg/kg of indomethacin was orally-administered to the rats to induce stomach ulcers. At 6 hours following the stomach ulcer-inducing drug administration, the rats were sacrificed.
  • the stomach of each specimen was enucleated and the pylorus of the stomach was then ligated. 3 mL of a 2% formalin solution was injected through the cardiac orifice and the specimen was fixed for 10 min. After completion of the fixation, the greater curvature of the stomach was excised and washed with physiological saline. The resulting greater curvature was thoroughly spread, fixed on a fixing plate and taken as a photograph. The length of injured site in the photograph was measured with a bio-imaging analyzer.
  • Stillene ® (Positive control drug) : available from Dong-a pharmaceutical Co. , Ltd.
  • Stomach ulcer area is represented by "average ⁇ standard error”. " * " represents statistical significance at 95% confidence level, in contrast with control groups.
  • Example 4 Stomach Ulcer Treatment Effects of Freeze-dried Earthworm Powder on Stomach Ulcer Model 6 week-old white Wistar male rats were used as subjects. Stomach ulcers were induced by a Water-Immersion Restraint Stress Model in the same manner as Example 2. Stomach ulcer-induction (water-immersion) was performed for three days, once per day, that is, three times in total. In the first day, after the rats were subjected to water- immersion for 3 hours, they were isolated from a bath and transferred into a breeding cage. At 3 hours following the water-immersion, a test drug (Omeprazole 10 mg/kg, Stillene ® 60 mg/kg or freeze-dried earthworm powder 50 mg/kg) was orally-administered to the rats.
  • a test drug Omeprazole 10 mg/kg, Stillene ® 60 mg/kg or freeze-dried earthworm powder 50 mg/kg
  • the water-immersion was carried out for 2 hours and the test drugs were administered to the rats in the same dosage as in the first day at one hour prior to water-immersion and at three hours after the completion of water-immersion.
  • water-immersion and drug administration were carried out in the same manner as in the second day.
  • the rats were sacrificed and the stomach thereof was enucleated.
  • the pylorus of the stomach was then ligated.
  • 3 mL of a 2% formalin solution was injected through the cardiac orifice and the specimen was fixed for 10 min.
  • the greater curvature of the stomach was excised and washed with physiological saline.
  • the resulting greater curvature was thoroughly spread, fixed on a fixing plate and taken as a photograph.
  • the area of injured site in the photograph was measured with a bio-imaging analyzer.
  • Table 3 Stomach Ulcer Treatment Effects of Freeze-dried Earthworm Powder on Stomach Ulcers Induced by Water- Immersion Restraint Stress
  • Stillene ® (Positive control drug) : available from Dong-a pharmaceutical Co., Ltd.
  • Omeprazole used in only Example 4, where a stomach ulcer treatment effect is tested, as ingredient of stomach ulcer drug available from Sigma Co., Ltd.
  • Stomach ulcer area is represented by "average ⁇ standard error”.
  • w * Ii represents statistical significance at 95% confidence level, in contrast with control groups.
  • Example 5 Tests with Earthworm-extracted Supernatant The tests were performed in the same manner as in Examples 2 to 4 , except that 8.5 kg of the earthworm- extracted supernatant prepared in Example 1 was used instead of the freeze-dried earthworm powder. Since the earthworm- extracted supernatant has a weight, about 7-fold higher than that of the freeze-dried earthworm powder, it was used in an amount corresponding to 7-fold of the weight of the freeze- dried earthworm powder used in Examples 2 to 4.
  • the anti-stomach ulcer composition of the present invention is efficacious in preventing and treating stomach ulcers, thus being industrially applicable.
  • w * " represents statistical significance at 95% confidence level, in contrast with control groups.
  • Example 5 Tests with Earthworm-extracted Supernatant The tests were performed in the same manner as in Examples 2 to 4 , except that 8.5 kg of the earthworm- extracted supernatant prepared in Example 1 was used instead of the freeze-dried earthworm powder. Since the earthworm- extracted supernatant has a weight, about 7-fold higher than that of the freeze-dried earthworm powder, it was used in an amount corresponding to 7-fold of the weight of the freeze- dried earthworm powder used in Examples 2 to 4.
  • the anti-stomach ulcer composition of the present invention is efficacious in preventing and treating stomach ulcers, thus being industrially applicable.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed herein is a composition for preventing and treating stomach ulcers. The composition comprises a freeze- dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying. The composition is efficacious in preventing and treating stomach ulcers.

Description

ANTI STOMACH ULCER OR STOMACH ULCER DRUG COMPOSITION
[Technical Field]
The present invention relates to a composition for preventing or treating stomach ulcers. More specifically, the present invention relates to a composition efficacious in preventing or treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms, and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying.
[Background Art]
Dried earthworm powders or earthworm extracts have been used for antihyperlipemic, antidiabetic, blood pressure-controlling and antithrombosis drugs. Such use is based on their medical efficacies recorded in Oriental Medicine Literatures (Shinnongbonchogyeong, etc). However, the present inventors have demonstrated that lumbrokinase contained in earthworms is efficacious in treating stomach ulcers via repeated research and tests, taking into consideration the facts that earthworms contain a great amount of lumbrokinase, which is one of the proteases, and that a great deal of protease activated receptors (PARs) which have activities for lumbrokinase are present in a human's stomach. As a result, the present invention has been finally completed.
Lumbrokinase contained in earthworms is reported to be a serine-based protease, be considerably stable against heat or pH and exhibit a specific activity for fibrin, which is one of thrombus' ingredients. Lumbrokinase administered orally must be released through the intestines into blood so that it can exert its efficacy. Research associated with this release is considered to be recently conducted.
It was reported that a great deal of protease activated receptors (PARs) present in the gastrointestines are associated with protection functions of gastrointestinal systems .
Accordingly, the present inventors ascertained efficacy of freeze-dried earthworm powders on stomach ulcer- inducing models through various methods. [Disclosure] [Technical Problem]
The present invention has been made to solve the foregoing problems of the prior art and it is an aspect of the present invention to provide a composition for preventing and treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms, and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying.
[Technical Solution]
In accordance with an aspect of the present invention for achieving the above aspect, there is provided a composition for preventing and treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant, both of which contain lumbrokinase as an active ingredient, wherein the earthworm-extracted supernatant is prepared by wet-grinding living earthworms and centrifuging the grinded earthworms, and the freeze-dried earthworm powder is obtained by filtering the supernatant, followed by freeze-drying .
[Advantageous Effects]
The composition of the present invention is efficacious in preventing and treating stomach ulcers.
[Description of Drawings]
The above and other aspects, features and other advantages of the present invention will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings, in which: FIGs. 1 and 2 are photographs showing the gastrointestines of a control group in Example 4 according to the present invention;
FIGs. 3 and 4 are photographs showing the gastrointestines of a white rat to which Omeprazole is administered in Example 4 according to the present invention;
FIGs. 5 and 6 are photographs showing the gastrointestines of a white rat to which Stillene is administered in Example 4 according to the present invention; and
FIGs . 7 and 8 are photographs showing the gastrointestines of a white rat to which a freeze-dried earthworm powder is administered in Example 4 according to the present invention. [Best Mode]
The present invention will now be described with reference to the accompanying drawings in greater detail.
The anti-stomach ulcer composition according to the present invention comprises a freeze-dried earthworm powder or a supernatant extracted from earthworms (hereinafter, referred to simply as "earthworm supernatant") . Preferably, the anti-stomach ulcer composition contains lumbrokinase , which is one of the proteases, as an active ingredient.
A method for preparing the anti-stomach ulcer composition of the present invention comprises: washing raw earthworms with distilled water; wet-grinding the earthworms; centrifuging the earthworms at 2,000χg to 4,000*g for 20 to 40 min to obtain a supernatant; and preparing a supernatant-containing composition for preventing and treating stomach ulcers. Preferably, the method may further comprise filtering the supernatant through diatomaceous silica to remove water- insoluble materials.
Preferably, the method may further comprise freeze-drying the supernatant to prepare a freeze-dried earthworm powder. The preparation of the anti-stomach ulcer composition is carried out using the freeze-dried earthworm powder.
[Mode for Invention]
The present invention will be better understood from the following examples. These examples are not to be construed as limiting the scope of the invention.
EXAMPLES Example 1 : Preparation of Freeze-dried Earthworm Powder
Of earthworms belonging to the Phylum Annelida, Subclass Oligochaeta, red worms (Lumbricus rubellus) , tiger worms (Eisenia fetida), large reddish worms (Lumbricus terrestris) , or red tiger worms (Eisenia andrei) were purchased from a farm breeding earthworms for feeds and fishing baits. 10 Kg of raw worms were thoroughly washed with distilled water to remove foreign materials and subjected to wet-grinding. The resulting worms were centrifuged at 3,000*g for 30 min to obtain a supernatant (8.5 kg). The supernatant was filtered through diatomaceous silica to separate water-insoluble materials therefrom. The resulting residue was freeze-dried to prepare a freeze-dried earthworm powder. The weight of the freeze-dried earthworm powder obtained from the raw earthworms (10 Kg) was 1.2 Kg and a titer of a casein digestion was 870 units /g.
Example 2: Effects of Stomach Ulcer Protection on Stomach Ulcer Model Induced by Stress 6 week-old white Wistar male rats were used as subjects. Stomach ulcers were induced by a Water-Immersion Restraint Stress Model in which white rats are immersed in a bath. This model is to induce rats to have acute stomach ulcers by forcing the rats to be immersed in a stress cage containing water they hate for 6 hours. A test drug (Stillene® 60 mg/kg or freeze-dried earthworm powder 50 mg/kg) was administered to the rats at 30 minutes before water-immersion. The temperature of the bath was maintained at 21°C to 23°C. After completion of the immersion, the stomach of each specimen was enucleated and the pylorus of the stomach was then ligated. Then, 3 mL of a 2% formalin solution was injected through the cardiac orifice and the specimen was fixed for 10 min. After completion of the fixation, the greater curvature of the stomach was excised and washed with physiological saline. The resulting greater curvature was thoroughly spread, fixed on a fixing plate and taken as a photograph. The area of injured site in the photograph was measured with a bio-imaging analyzer.
The results were shown in Table 1. An experimental group, to which 50 mg/kg of the freeze-dried earthworm powder was administered, exhibited stomach ulcer inhibition of 50.2%, as compared to a negative control group, to which no drug was administered. A positive control group, to which Stillene was administered, exhibited stomach ulcer inhibition of 18.1%.
Table 1: Effects of Freeze-dried Earthworm Powder on Stomach Ulcers Induced by Water-Immersion Restraint Stress
Figure imgf000009_0001
Stillene® (Positive control drug): available from Dong-a pharmaceutical Co. , Ltd.
Stomach ulcer area is represented by "average ± standard error".
" * " represents statistical significance at 95% confidence level, in contrast with control groups.
Example 3: Effects of Stomach Ulcer Protection on Stomach Ulcer Model Induced by Drug
6 week-old white Wistar male rats were used as subjects. A stomach ulcer-inducing drug used herein was indomethacin, one of non-steroidal anti- inflammatory drugs. The indomethacin was reported to inhibit activity of cyclooxygenase that participates in prostacyclin synthesis in gastric cells, causing gastric injury. A test drug (Stillene* 60 mg/kg or freeze-dried earthworm powder 50 mg/kg) was administered to the Wistar rats, which had been fasted during the overnight prior to testing. After 30 minutes, 20 mg/kg of indomethacin was orally-administered to the rats to induce stomach ulcers. At 6 hours following the stomach ulcer-inducing drug administration, the rats were sacrificed. The stomach of each specimen was enucleated and the pylorus of the stomach was then ligated. 3 mL of a 2% formalin solution was injected through the cardiac orifice and the specimen was fixed for 10 min. After completion of the fixation, the greater curvature of the stomach was excised and washed with physiological saline. The resulting greater curvature was thoroughly spread, fixed on a fixing plate and taken as a photograph. The length of injured site in the photograph was measured with a bio-imaging analyzer.
The results were shown in Table 2. An experimental group, to which 50 mg/kg of the freeze-dried earthworm powder was administered, exhibited stomach ulcer inhibition of 46.8%, as compared to a negative control group, to which no drug was administered. A positive control group, to which Stillene was administered, exhibited stomach ulcer inhibition of about 13.2%.
Table 2: Effects of Freeze-dried Earthworm Powder on Stomach Ulcers Induced by Drug
Figure imgf000011_0001
Stillene® (Positive control drug) : available from Dong-a pharmaceutical Co. , Ltd.
Stomach ulcer area is represented by "average ± standard error". " * " represents statistical significance at 95% confidence level, in contrast with control groups.
Example 4: Stomach Ulcer Treatment Effects of Freeze-dried Earthworm Powder on Stomach Ulcer Model 6 week-old white Wistar male rats were used as subjects. Stomach ulcers were induced by a Water-Immersion Restraint Stress Model in the same manner as Example 2. Stomach ulcer-induction (water-immersion) was performed for three days, once per day, that is, three times in total. In the first day, after the rats were subjected to water- immersion for 3 hours, they were isolated from a bath and transferred into a breeding cage. At 3 hours following the water-immersion, a test drug (Omeprazole 10 mg/kg, Stillene® 60 mg/kg or freeze-dried earthworm powder 50 mg/kg) was orally-administered to the rats. In the second day, the water-immersion was carried out for 2 hours and the test drugs were administered to the rats in the same dosage as in the first day at one hour prior to water-immersion and at three hours after the completion of water-immersion. In the third day, water-immersion and drug administration were carried out in the same manner as in the second day. At 3 hours following the drug administration, the rats were sacrificed and the stomach thereof was enucleated. The pylorus of the stomach was then ligated. Then, 3 mL of a 2% formalin solution was injected through the cardiac orifice and the specimen was fixed for 10 min. After completion of the fixation, the greater curvature of the stomach was excised and washed with physiological saline. The resulting greater curvature was thoroughly spread, fixed on a fixing plate and taken as a photograph. The area of injured site in the photograph was measured with a bio-imaging analyzer.
The results were shown in Table 3 and FIGs. 1 to 8. An experimental group, to which 50 mg/kg of the freeze-dried earthworm powder was administered, exhibited stomach ulcer inhibition of 72.2%, as compared to a negative control group, to which no drug was administered. One positive control group, to which Omeprazole was administered, exhibited stomach ulcer inhibition of 71.6%. Another positive control group, to which Stillene was administered, exhibited stomach ulcer inhibition of about 18%. These results indicate that the freeze-dried earthworm powder exhibits excellent inhibitory activity for stomach ulcers induced by water- immersion restraint stress, which is higher than that of Stillene, and furthermore, comparable to that of Omeprazole.
Table 3: Stomach Ulcer Treatment Effects of Freeze-dried Earthworm Powder on Stomach Ulcers Induced by Water- Immersion Restraint Stress
Figure imgf000014_0001
Stillene® (Positive control drug) : available from Dong-a pharmaceutical Co., Ltd.
Omeprazole (Positive control drug): used in only Example 4, where a stomach ulcer treatment effect is tested, as ingredient of stomach ulcer drug available from Sigma Co., Ltd.
Stomach ulcer area is represented by "average ± standard error". w * Ii represents statistical significance at 95% confidence level, in contrast with control groups.
Example 5 : Tests with Earthworm-extracted Supernatant The tests were performed in the same manner as in Examples 2 to 4 , except that 8.5 kg of the earthworm- extracted supernatant prepared in Example 1 was used instead of the freeze-dried earthworm powder. Since the earthworm- extracted supernatant has a weight, about 7-fold higher than that of the freeze-dried earthworm powder, it was used in an amount corresponding to 7-fold of the weight of the freeze- dried earthworm powder used in Examples 2 to 4.
The results obtained from this Example were substantially the same as in Examples 2 to 4.
[Industrial Applicability]
As apparent from the foregoing, the anti-stomach ulcer composition of the present invention is efficacious in preventing and treating stomach ulcers, thus being industrially applicable. w * " represents statistical significance at 95% confidence level, in contrast with control groups.
Example 5 : Tests with Earthworm-extracted Supernatant The tests were performed in the same manner as in Examples 2 to 4 , except that 8.5 kg of the earthworm- extracted supernatant prepared in Example 1 was used instead of the freeze-dried earthworm powder. Since the earthworm- extracted supernatant has a weight, about 7-fold higher than that of the freeze-dried earthworm powder, it was used in an amount corresponding to 7-fold of the weight of the freeze- dried earthworm powder used in Examples 2 to 4.
The results obtained from this Example were substantially the same as in Examples 2 to 4.
[Industrial Applicability]
As apparent from the foregoing, the anti-stomach ulcer composition of the present invention is efficacious in preventing and treating stomach ulcers, thus being industrially applicable.
- 14 -

Claims

[CLAIMS]
[Claim 1]
A composition for preventing or treating stomach ulcers comprising a freeze-dried earthworm powder or an earthworm-extracted supernatant.
[Claim 2]
The composition according to claim 1, wherein the freeze- dried earthworm powder and the earthworm-extracted supernatant contain lumbrokinase, one of the proteases, as an active ingredient.
[Claim 3] A method for preparing the composition according to claim 1 or 2 comprising: washing raw earthworms with distilled water; wet-grinding the earthworms; centrifuging the earthworms at 2,000*g to 4,000χg for 20 to 40 min to obtain a supernatant; and preparing a supernatant-containing composition for preventing and treating stomach ulcers.
[Claim 4]
- 15 -
PCT/KR2007/002693 2006-07-25 2007-06-04 Anti stomach ulcer or stomach ulcer drug composition Ceased WO2008013362A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2006-0069987 2006-07-25
KR1020060069987A KR100814201B1 (en) 2006-07-25 2006-07-25 Pharmaceutical composition for anti-gastric ulcer or gastric ulcer treatment

Publications (1)

Publication Number Publication Date
WO2008013362A1 true WO2008013362A1 (en) 2008-01-31

Family

ID=38981654

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/002693 Ceased WO2008013362A1 (en) 2006-07-25 2007-06-04 Anti stomach ulcer or stomach ulcer drug composition

Country Status (2)

Country Link
KR (1) KR100814201B1 (en)
WO (1) WO2008013362A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010029453A1 (en) * 2008-09-10 2010-03-18 Pt.Dexa Medica Composition of thrombolytic agent and anti thrombosis and also its production method
CN106955355A (en) * 2016-01-08 2017-07-18 北京百奥药业有限责任公司 Pharmaceutical composition, preparation and its application of statins and Lumbrokinase

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568545A (en) * 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
EP0383533B1 (en) * 1989-02-15 1994-08-24 Eimei Company Ltd Therapeutic medicament for thrombosis and method for preparation thereof
KR20000003837A (en) * 1998-06-29 2000-01-25 장용택 Immune enhancer containing lombricine as effective ingredient
KR20050107640A (en) * 2004-05-10 2005-11-15 신풍제약주식회사 Process for preparing protease powder from lumbricus rubellus using an organic solvent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568545A (en) * 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
EP0383533B1 (en) * 1989-02-15 1994-08-24 Eimei Company Ltd Therapeutic medicament for thrombosis and method for preparation thereof
KR20000003837A (en) * 1998-06-29 2000-01-25 장용택 Immune enhancer containing lombricine as effective ingredient
KR20050107640A (en) * 2004-05-10 2005-11-15 신풍제약주식회사 Process for preparing protease powder from lumbricus rubellus using an organic solvent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010029453A1 (en) * 2008-09-10 2010-03-18 Pt.Dexa Medica Composition of thrombolytic agent and anti thrombosis and also its production method
CN106955355A (en) * 2016-01-08 2017-07-18 北京百奥药业有限责任公司 Pharmaceutical composition, preparation and its application of statins and Lumbrokinase

Also Published As

Publication number Publication date
KR100814201B1 (en) 2008-03-17
KR20080010040A (en) 2008-01-30

Similar Documents

Publication Publication Date Title
CA1148864A (en) Pharmaceutical compositions particularly for cancer treatment
Mitchell et al. Researches upon the venoms of poisonous serpents
CA1169775A (en) Anti-ischemic pharmaceutical composition
WO2008013362A1 (en) Anti stomach ulcer or stomach ulcer drug composition
CN101780227B (en) Traditional Chinese medicine composition for treating acute stroke and preparation method thereof
CN102321072B (en) Esomeprazole sodium hemihydrate
US20210308192A1 (en) Composition for preventing or treating ischemic enteritis containing dna fragment mixture isolated from sperm or testis of fish
KR101072247B1 (en) Processed Aloe vera for preventing or treating a hepatic disease and a combination therapy processed Aloe vera with milk thistle
CN116712461A (en) Application of artificial tiger bone powder (Jintiange capsule) in preventing or treating skeletal muscle atrophy
CN1257907C (en) Ginkgo lactone compound and its preparation and medicinal composition containing it
WO2022106851A1 (en) Mebendazole for use in the treatment of autosomal dominant polycystic kidney disease or autosomal recessive polycystic kidney disease
US20100003348A1 (en) Use of clays for treating coeliac disease
RU2390348C1 (en) Drug stabinorm for treating chronic fatigue syndrome
CN110448562A (en) Application of the lupenone in preparation treatment renal damage drug
EP1358887B1 (en) Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
WO2006042387A1 (en) Drugs derived from diclofenac containing no-donor heterocycles, composition and method of inflammation treatment
WO2008002019A1 (en) Anti-hangover composition
JPH02215726A (en) Diabete remedy
CN117599062B (en) Composition for assisting in improving memory and preventing or treating Alzheimer disease
JPS5965018A (en) Treating and preventing agent for peptic ulcer
JPS63170315A (en) Growth hormone releasing agent containing 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-d]azepine as an active ingredient
Ahmed et al. Impact of metformin onto ischemia-reperfusion damage of the kidney
RU2242975C2 (en) Agent for applying in transplantation
CN116173134A (en) Application of a traditional Chinese medicine composition in preparation of medicine for treating organ fibrosis
CN110237067A (en) Application of apigenin and its derivatives in the preparation of medicines for treating or preventing nephropathy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07807911

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A OF 23.07.2009

122 Ep: pct application non-entry in european phase

Ref document number: 07807911

Country of ref document: EP

Kind code of ref document: A1